Viewing Study NCT02054351


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-01-01 @ 8:20 PM
Study NCT ID: NCT02054351
Status: COMPLETED
Last Update Posted: 2024-11-21
First Post: 2014-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)
Sponsor: Ganymed Pharmaceuticals GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module